05.05.2015 20:29:00
|
New appointment to Arkema’s Board of Directors
Regulatory News:
ARKEMA (Paris:AKE):
Arkema’s Board of Directors, at a meeting on 5 May 2015, decided to propose to the forthcoming annual general meeting on 2 June 2015 the appointment of Mrs Hélène Moreau-Leroy as Director of Arkema for a four-year term.
Hélène Moreau-Leroy is Chairman and CEO of Hispano-Suiza (Safran Group) and has been a member of the Safran Executive Committee since 1st July 2013.
Her appointment will enable Arkema’s Board of Directors to fully benefit from her experience in senior management, as well as her proven industrial expertise and long-standing international experience.
Subject to her appointment as director by the annual general meeting, Mrs Hélène Moreau-Leroy would be qualified as an independent director according to the criteria set by the Company in accordance with the AFEP-MEDEF Code. The Board of Directors also decided that she would be appointed a member of the Audit and Accounts Committee.
Born in 1964, Hélène Moreau-Leroy is a graduate engineer from INSA Lyon, and holds a Master’s in International Business Administration (University of New England, Australia). She is a certified supply chain professional (APICS).
She has held a number of management positions in R&D, project management, procurement and production in industrial groups, and spent 14 years of her career outside France in international posts. She joined the Safran Group in 2003 in the Group Purchasing Department of Snecma SA. She then oversaw the implementation of Messier-Bugatti Dowty’s supply chain in emerging countries before she became Executive Vice-President of Programs and a member of the Management Committee.
Hélène Moreau-Leroy is also a member of the Steering Committee of the Groupement des Equipementiers de l’Aéronautique et Défense (GEAD) and a member of networks and associations promoting diversity in the workplace.
Meanwhile, to accommodate current and future changes in the Board’s composition, and in the light of Arkema’s significant evolution, the Board wishes to have more flexibility to ensure that the Company’s key competencies and continuity of knowledge are safeguarded within it. Accordingly, the Board will recommend to this next annual general meeting that it be allowed, in the event of a director reaching the statutory age limit of 70 years during their term of office, to decide that the director in question could complete their term of office.
A global chemical company and France’s leading chemicals producer, Arkema is building the future of the chemical industry every day. Deploying a responsible, innovation-based approach, we produce state-of-the-art specialty chemicals that provide customers with practical solutions to such challenges as climate change, access to drinking water, the future of energy, fossil fuel preservation and the need for lighter materials. With operations in close to 50 countries, some 19,000 employees and research centers in North America, France and Asia, Arkema generates pro forma annual revenue of some €7.5 billion, and holds leadership positions in all its markets with a portfolio of internationally recognized brands.
ARKEMA
420, rue d’Estienne d’Orves – F-92705 COLOMBES Cedex
– France
Standard : +33 (0)1 49 00 80 80 – Fax : +33 (0)1 49 00 83
96
Société anonyme au capital de 728 226 950 euros – 445 074 685
RCS Nanterre
arkema.com
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu ArkemaAct.mehr Nachrichten
05.11.24 |
Ausblick: ArkemaAct vermeldet Zahlen zum jüngsten Quartal (finanzen.net) | |
22.10.24 |
Erste Schätzungen: ArkemaAct gewährt Anlegern Blick in die Bücher (finanzen.net) | |
31.07.24 |
Ausblick: ArkemaAct mit Zahlen zum abgelaufenen Quartal (finanzen.net) | |
17.07.24 |
Erste Schätzungen: ArkemaAct stellt Zahlen zum jüngsten Quartal vor (finanzen.net) |